DMPK is an acronym that stands for drug metabolism and pharmacokinetics. This is a discipline that helps to identify drugs that are likely to be suitable for advancement through the drug development process. It considers how the drug is metabolized and processed by the body.

The global DMPK Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime' newest research report, the “DMPK Service Industry Forecast” looks at past sales and reviews total world DMPK Service sales in 2022, providing a comprehensive analysis by region and market sector of projected DMPK Service sales for 2023 through 2029. With DMPK Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DMPK Service industry.

This Insight Report provides a comprehensive analysis of the global DMPK Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

This report also splits the market by region.

Segmentation by Type:

• Small Molecules
• Biologics

Segmentation by Application:

• Biopharmaceutical Companies
• Government and Academic Institutes
• Others

Market by Region:

• Americas
• APAC
• Europe
• Middle East & Africa

Company's Coverage:

• Eurofins Discovery
• Inotiv
• Evotec
• Sai Life Sciences
• Sygnature Discovery
• WuXi AppTec
• Hangzhou Tigermed Consulting Co
• Q2 Solutions
• Jubilant Biosys
• Frontage Laboratories
• Invitrocue
• Creative Biolabs
• CrownBioscience
• Agilent
• H3D
• LABCORP
• Bioduro-Sundia
• Allucent

Key Questions Addressed in This Report